Crossmark

Abordaje terapéutico del SARS-CoV-2 (COVID-19) mediante células mesenquimales de médula ósea alogénica expandidas. Conceptos a propósito de un primer caso en España

Crossref DOI link: https://doi.org/10.1016/j.medcli.2020.06.018

Published Print: 2020-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Soler Rich, Robert

Rius Tarruella, Joan

Melgosa Camarero, María Teresa
License Information

Text and Data Mining valid from 2020-10-01
More Information

This article is maintained by: Elsevier

Article Title: Abordaje terapéutico del SARS-CoV-2 (COVID-19) mediante células mesenquimales de médula ósea alogénica expandidas. Conceptos a propósito de un primer caso en España

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2020.06.018

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below